Tilray Brands and Canopy Growth jumped more than 40 per cent in New York trading. A specialist fund, the Amplify Seymour ...
Much of the potential insurance upside hinges on the banking system. Groshans argued that rescheduling would encourage banks ...
Marijuana currently is classified as a Schedule I drug, which the DEA describes as substances with no "medical use and a high ...
Shares of cannabis companies jumped on Friday after the Washington Post reported U.S. President Donald Trump is expected to ...
Canopy Growth ( CGC +44.69%) stock soared 17% through 12:50 p.m. ET Friday on some positive marijuana news out of the White ...